{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:18:19Z","timestamp":1790738299561,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s13346-023-01339-2","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T13:02:16Z","timestamp":1683118936000},"page":"2589-2603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Development of doxorubicin-encapsulated magnetic liposome@PEG for treatment of breast cancer in BALB\/c mice"],"prefix":"10.1007","volume":"13","author":[{"given":"Sajjad","family":"Maghsoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3969-3241","authenticated-orcid":false,"given":"Seyed Ali","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Soraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Roosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Mohammadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"issue":"3","key":"1339_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin."},{"issue":"15","key":"1339_CR2","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3390\/polym14153027","volume":"14","author":"A Kumar","year":"2022","unstructured":"Kumar A, et al. Polymer-based hybrid nanoarchitectures for cancer therapy applications. Polymers. 2022;14(15):3027.","journal-title":"Polymers"},{"issue":"1","key":"1339_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10717544.2020.1853281","volume":"28","author":"R Van Durme","year":"2021","unstructured":"Van Durme R, et al. Model-based optimized steering and focusing of local magnetic particle concentrations for targeted drug delivery. Drug Deliv. 2021;28(1):63\u201376.","journal-title":"Drug Deliv"},{"key":"1339_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/B978-0-12-816960-5.00011-2","volume-title":"Metal nanoparticles for drug delivery and diagnostic applications","author":"S Mirza","year":"2020","unstructured":"Mirza S, et al. Magnetic nanoparticles: drug delivery and bioimaging applications. In: Metal nanoparticles for drug delivery and diagnostic applications. Elsevier; 2020. p. 189\u2013213."},{"key":"1339_CR5","doi-asserted-by":"crossref","unstructured":"Price PM, et al. Magnetic drug delivery: where the field is going. Front Chem.\u00a02018:619.","DOI":"10.3389\/fchem.2018.00619"},{"issue":"6","key":"1339_CR6","doi-asserted-by":"publisher","first-page":"e1571","DOI":"10.1002\/wnan.1571","volume":"11","author":"JF Liu","year":"2019","unstructured":"Liu JF, et al. Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11(6):e1571.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol."},{"key":"1339_CR7","doi-asserted-by":"publisher","first-page":"102916","DOI":"10.1016\/j.jddst.2021.102916","volume":"66","author":"M Bilal","year":"2021","unstructured":"Bilal M, et al. Stimuli-responsive nanoliposomes as prospective nanocarriers for targeted drug delivery. J Drug Deliv Sci Technol. 2021;66:102916.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"1339_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s12951-022-01760-8","volume":"20","author":"B Yan","year":"2022","unstructured":"Yan B, et al. Engineering magnetic nano-manipulators for boosting cancer immunotherapy. J Nanobiotechnol. 2022;20(1):547.","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"1339_CR9","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, et al. Lipid nanoparticles\u2500 from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15(11):16982\u20137015.","journal-title":"ACS Nano"},{"key":"1339_CR10","doi-asserted-by":"crossref","unstructured":"Pandey H, Rani R, Agarwal V. Liposome and their applications in cancer therapy. Braz Arch Biol Technol.\u00a02016;59.","DOI":"10.1590\/1678-4324-2016150477"},{"issue":"3","key":"1339_CR11","first-page":"217","volume":"67","author":"S Dash","year":"2010","unstructured":"Dash S, et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217\u201323.","journal-title":"Acta Pol Pharm"},{"key":"1339_CR12","doi-asserted-by":"crossref","unstructured":"Santadkha T, Skolpap W, Thitapakorn V. Diffusion modeling and in vitro release kinetics studies of curcumin\u2212 loaded superparamagnetic nanomicelles in cancer drug delivery system. J Pharm Sci. 2022;111:1690\u201399.","DOI":"10.1016\/j.xphs.2021.11.015"},{"key":"1339_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jconrel.2020.05.047","volume":"324","author":"T Lu","year":"2020","unstructured":"Lu T, Ten Hagen TL. A novel kinetic model to describe the ultra-fast triggered release of thermosensitive liposomal drug delivery systems. J Control Release. 2020;324:669\u201378.","journal-title":"J Control Release"},{"issue":"01","key":"1339_CR14","first-page":"1","volume":"5","author":"A Al Sabah","year":"2021","unstructured":"Al Sabah A, Maghdoon R. Determination of cytotoxicity of anticancer drug doxorubicin and its side effects. Medbiotech J. 2021;5(01):1\u20135.","journal-title":"Medbiotech J."},{"issue":"11","key":"1339_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111960","volume":"9","author":"H Bassiony","year":"2014","unstructured":"Bassiony H, et al. Magnetite nanoparticles inhibit tumor growth and upregulate the expression of P53\/P16 in Ehrlich solid carcinoma bearing mice. PLoS One. 2014;9(11): e111960.","journal-title":"PLoS ONE"},{"key":"1339_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114227","volume":"159","author":"J Zhu","year":"2023","unstructured":"Zhu J, Wang J, Li Y. Recent advances in magnetic nanocarriers for tumor treatment. Biomed Pharmacother. 2023;159: 114227.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1339_CR17","first-page":"96","volume":"5","author":"H Sadeghi-Aliabadi","year":"2013","unstructured":"Sadeghi-Aliabadi H, et al. Preparation and cytotoxic evaluation of magnetite (Fe3O4) nanoparticles on breast cancer cells and its combinatory effects with doxorubicin used in hyperthermia. Avicenna J Med Biotechnol. 2013;5(2):96.","journal-title":"Avicenna J Med Biotechnol"},{"issue":"1","key":"1339_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10717544.2020.1853281","volume":"28","author":"R Van Durme","year":"2021","unstructured":"Van Durme R, et al. Model-based optimized steering and focusing of local magnetic particle concentrations for targeted drug delivery. Drug Deliv. 2021;28(1):63\u201376.","journal-title":"Drug Deliv"},{"issue":"8","key":"1339_CR19","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1088\/1361-6560\/aa5e90","volume":"62","author":"A Coene","year":"2017","unstructured":"Coene A, et al. Multi-color magnetic nanoparticle imaging using magnetorelaxometry. Phys Med Biol. 2017;62(8):3139\u201357.","journal-title":"Phys Med Biol"},{"key":"1339_CR20","doi-asserted-by":"crossref","unstructured":"Jannah N, Onggo D. Synthesis of Fe3O4 nanoparticles for colour removal of printing ink solution. Journal of Physics: Conference Series. 2019;1245:012040.\u00a0","DOI":"10.1088\/1742-6596\/1245\/1\/012040"},{"key":"1339_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.colsurfb.2014.03.001","volume":"117","author":"S Sadighian","year":"2014","unstructured":"Sadighian S, et al. Doxorubicin-conjugated core\u2013shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery. Colloids Surf B. 2014;117:406\u201313.","journal-title":"Colloids Surf B"},{"key":"1339_CR22","doi-asserted-by":"crossref","unstructured":"Ibrahim M, et al. Encapsulation, release, and cytotoxicity of doxorubicin loaded in liposomes, micelles, and metal-organic frameworks: a review. Pharmaceutics.\u00a02022;14(2):254.\u200f","DOI":"10.3390\/pharmaceutics14020254"},{"issue":"6","key":"1339_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07370","volume":"7","author":"DAA Fadeel","year":"2021","unstructured":"Fadeel DAA, et al. Novel greenly synthesized titanium dioxide nanoparticles compared to liposomes in drug delivery: in vivo investigation on Ehrlich solid tumor model. Heliyon. 2021;7(6): e07370.","journal-title":"Heliyon"},{"issue":"4","key":"1339_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12247-016-9253-x","volume":"11","author":"LG Bakre","year":"2016","unstructured":"Bakre LG, Sarvaiya JI, Agrawal YK. Synthesis, characterization, and study of drug release properties of curcumin from polycaprolactone\/organomodified montmorillonite nanocomposite. J Pharm Innov. 2016;11(4):300\u20137.","journal-title":"J Pharm Innov"},{"key":"1339_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109323","volume":"118","author":"J de Oliveira Silva","year":"2019","unstructured":"de Oliveira Silva J, et al. Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model. Biomed Pharmacother. 2019;118: 109323.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1339_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/21691401.2018.1548470","volume":"47","author":"D Cao","year":"2019","unstructured":"Cao D, et al. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer. Artificial Cells Nanomed Biotechnol. 2019;47(1):181\u201391.","journal-title":"Artificial Cells Nanomed Biotechnol"},{"issue":"20","key":"1339_CR27","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1021\/acs.langmuir.8b00411","volume":"34","author":"LO Monteiro","year":"2018","unstructured":"Monteiro LO, et al. Paclitaxel-loaded pH-sensitive liposome: new insights on structural and physicochemical characterization. Langmuir. 2018;34(20):5728\u201337.","journal-title":"Langmuir"},{"issue":"3","key":"1339_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/ph15030306","volume":"15","author":"R Huang","year":"2022","unstructured":"Huang R, et al. Imidazole-based pH-sensitive convertible liposomes for anticancer drug delivery. Pharmaceuticals. 2022;15(3):306.","journal-title":"Pharmaceuticals"},{"issue":"4","key":"1339_CR29","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s13738-019-01828-7","volume":"17","author":"R Dadashi","year":"2020","unstructured":"Dadashi R, Bahram M, Moghtader M. Multivariate curve resolution-alternating least squares to study the simultaneous release of Sumatriptan and Naproxen from the polymeric substrate. J Iran Chem Soc. 2020;17(4):953\u201362.","journal-title":"J Iran Chem Soc"},{"key":"1339_CR30","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.2147\/DDDT.S149814","volume":"11","author":"Y Ding","year":"2017","unstructured":"Ding Y, et al. In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB\/c nude mice bearing human breast tumors. Drug Des Dev Ther. 2017;11:3105.","journal-title":"Drug Des Dev Ther"},{"key":"1339_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118520","volume":"262","author":"N Ghandhariyoun","year":"2020","unstructured":"Ghandhariyoun N, et al. Reducing Doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: in vitro and in vivo. Life Sci. 2020;262: 118520.","journal-title":"Life Sci"},{"key":"1339_CR32","doi-asserted-by":"publisher","first-page":"8201","DOI":"10.2147\/IJN.S261671","volume":"15","author":"B Dorjsuren","year":"2020","unstructured":"Dorjsuren B, et al. Cetuximab-coated thermo-sensitive liposomes loaded with magnetic nanoparticles and doxorubicin for targeted EGFR-expressing breast cancer combined therapy. Int J Nanomed. 2020;15:8201.","journal-title":"Int J Nanomed"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01339-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-023-01339-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01339-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T14:10:36Z","timestamp":1693404636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-023-01339-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1339"],"URL":"https:\/\/doi.org\/10.1007\/s13346-023-01339-2","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,3]]},"assertion":[{"value":"21 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work has two ethics approval from Urmia University and Urmia University of Medical Sciences with ID of IR-UU-AEC-1504\/PD\/3 and IR-IMSU.AEC.1400.002, respectively. They are presented as supplementary data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}